Article Text
Statistics from Altmetric.com
Munthe et al1 argue for an asymmetry between positive and negative dynamics that justifies a new sustainability principle among the operational principles for ethical healthcare resource allocation. The purported asymmetry is that while positive dynamics are ‘taken into account in present applications of the operational principles…, negative dynamics are not’.1 Positive dynamics occur when allocations in the present lead to there being more healthcare resources per health need in the future (than are available in the present), whereas negative dynamics occur when present allocations lead to there being less future healthcare resources per health need.i Munthe et al1 are correct that we have ethical reason to reduce negative dynamics—all other things being equal, having less future healthcare resources per health need is worse than having more. Furthermore, this ethical reason ought to be accounted for by operational principles. However, using current examples from the COVID-19 response, I argue that allocation policies guided by existing operational principles already take into account negative dynamics and thus obviate the need for a new sustainability principle. Nevertheless, Munthe et al1 make a valuable contribution to the literature by opening up new lines of important research regarding the mitigation of allocation policies’ negative dynamics.
As Munthe et al1 cogently argue, existing healthcare allocation policies (eg, of vaccines) take positive dynamics into account. However, when they do so, they also often implicitly or …
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Linked Articles
Other content recommended for you
- Ethical issues raised by the introduction of payment for performance in France
- Ethical issues in funding orphan drug research and development
- Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision - making
- Gaps, conflicts, and consensus in the ethics statements of professional associations, medical groups, and health plans
- Ethical dilemmas in forensic psychiatry: two illustrative cases
- Conscientious participants and the ethical dimensions of physician support for legalised voluntary assisted dying
- Studying new antibiotics for multidrug resistant infections: are today ’s patients paying for unproved future benefits
- The bioethical principles and Confucius ’ moral philosophy
- Informal medicine: ethical analysis
- Should the practice of medicine be a deontological or utilitarian enterprise